All the news Showing 10 of 110 articles from: Hepatitis C eliminationGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Can the UK achieve the WHO hepatitis C eradication target? Drug & Alcohol Findings / 08 February 2019 In Egypt, Viral Hepatitis Elimination Starts With a Village: An Interview With Dr. Ammal Metwally IS Global / 05 February 2019 England: Countdown to hep C eradication Drink & Drug News / 05 February 2019 Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost Michael Carter / 01 February 2019 Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved ... WHO hepatitis C elimination targets are achievable, model shows – if 51 million treated by 2030 Keith Alcorn / 29 January 2019 Expanding hepatitis C screening to diagnose 90% of people by 2030, providing treatment to everyone with hepatitis C, scaling up harm reduction and improving blood and medical safety would avert ... UK court dismisses AbbVie's legal challenge against the NHS The Lancet (free registration required) / 25 January 2019 New Hepatitis C Strains Could Harm World Eradication Goals MD Magazine / 21 January 2019 Cairo, Khartoum reach deals to eradicate Hepatitis C, Diabetes in Sudan Egyptoday / 18 January 2019 NHS England’s plan to eliminate Hepatitis C decisively backed by High Court NHS England / 18 January 2019 Egypt proposes plan to treat African Hepatitis C patients Egypttoday / 16 January 2019 ← Prev1...45678...11Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds